S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

OLN Olin Corp

32.60

-0.84 (-2.51%)

Jan 24 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

Olin (NYSE:OLN)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Olin Charts.

Olin (NYSE:OLN)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Olin Charts.

Olin Corp News

Form 8-K - Current report
Tuesday 21 January 2025 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 21 January 2025 (5 days ago) • Edgar (US Regulatory)

Olin - Winchester to Acquire Ammunition Assets of AMMO, Inc.
Tuesday 21 January 2025 (5 days ago) • PR Newswire (US)

Olin Corporation Fourth Quarter 2024 Earnings Conference Call Announcement
Tuesday 7 January 2025 (3 weeks ago) • PR Newswire (US)

Form 8-K - Current report
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

Olin Hosts 2024 Investor Day and Announces Increase in Share Repurchase Authorization to $2.0 Billion
Thursday 12 December 2024 (1 month ago) • PR Newswire (US)

Form 8-K - Current report
Tuesday 10 December 2024 (2 months ago) • Edgar (US Regulatory)

Reminder to Join Olin Corporation's Investor Day on December 12, 2024
Monday 9 December 2024 (2 months ago) • PR Newswire (US)

Form 8-K - Current report
Thursday 21 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 20 November 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

More Olin Corp News Articles

TransCode Therapeutics

MineralRite (PK)

NioCorp Developments

Kraig Biocraft Laborator... (QB)

Bioelectronics (PK)

TheGlobe com (PK)

Elite Pharmaceuticals (QB)

Anavex Life Sciences

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

North Bay Resources (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions